RESUMEN
La salud mental del personal interviniente en primera línea de respuesta ante COVID-19, está bajo condiciones de estrés excepcional. Cada ámbito laboral, cobra sus propias características respecto a impactos psicosociales, niveles de afectación y cuidados necesarios. El trabajo dará cuenta del proceso y acciones de Salud Mental y Apoyo Psicosocial (SMAPS), cuyo principal objetivo fue detectar tempranamente el impacto psicosocial de los trabajadores, buscando mitigar la cronificación de sus consecuencias, ligadas al estrés y a las problemáticas del desgaste laboral. Las acciones fueron llevadas a cabo con un equipo de trabajadores sanitarios de intervención telefónica del Centro de Operaciones de Emergencias (COE) del Ministerio de Salud de la Ciudad de Buenos Aires. La implementación temprana de dispositivos de cuidados en SMAPS, ha colaborado a reducir el impacto psicosocial en el equipo de trabajo; asimismo el fortalecimiento de los vínculos entre compañeros y coordinadores, han funcionado como principal "Soporte social", considerando que "reestablecer la conexión, el lazo social arrasado por la irrupción del incidente crítico, permite ofrecer al afectado un marco de seguridad que pone un límite a la sensación de desvalimiento e indefensión" (Bentolila S. , 2020)(AU)
The mental health of the workers involves in the first line of response to COVID-19 is under conditions of exceptional stress. Each work environment has its own characteristics regarding psychosocial impacts, levels of affectation and necessary care. We try to show the process and actions of Mental Health and Psychosocial Support (SMAPS), whose main objective was to detect early the psychosocial impact of workers, seeking to mitigate the chronification of its consequences, linked to stress and the problems of work exhaustion. The actions were carried out with a team of telephone intervention health workers from the Emergency Operations Center (COE) of the Ministry of Health of the City of Buenos Aires. The early implementation of care devices in SMAPS has contributed to reducing the psychosocial impact on the work team; Likewise, the strengthening relationships between colleagues and coordinators has functioned as the main "social support", considering that " to restore the connection, the social bond devastated by the irruption of the critical incident, allows the affected person to be offered a security environment that sets a limit to the feeling of helplessness and defenselessness "(Bentolila S., 2020)(AU)
Asunto(s)
Humanos , Salud Mental , COVID-19 , Personal de Salud , Sistemas de Apoyo PsicosocialRESUMEN
OBJECTIVE: Early diagnosis and treatment initiation are important factors for successful treatment of mucopolysaccharidosis type I (MPS I). The purpose of this observational study was to assess whether age at diagnosis and time to first treatment for individuals with MPS I have improved over the last 15 years. STUDY DESIGN: Data from the MPS I Registry (NCT00144794) for individuals with attenuated or severe disease who initiated therapy with laronidase enzyme replacement therapy (ERT) and/or hematopoietic stem cell transplantation (HSCT) between 1 January 2003 and 31 December 2017 were included. RESULTS: Data were available for 740 individuals with attenuated (n=291) or severe (n=424) MPS I (unknown n=25). Median age at diagnosis for attenuated disease did not change over time and ranged between 4.5 and 6 years of age while the median duration from diagnosis to first ERT decreased from 5.6 years before/during 2004 to 2.4 months in 2014-2017. For severe MPS I treated with HSCT, median age at diagnosis was less than 1 year and median time to first treatment was less than 3 months throughout the 15-year observation period. CONCLUSIONS: Times to diagnosis and HSCT initiation for individuals with severe MPS I were consistent over time. For individuals with attenuated MPS I, the time to ERT initiation after diagnosis has improved substantially in the last 15 years, but median age at diagnosis has not improved. Efforts to improve early diagnosis in attenuated MPS I are needed to ensure that patients receive appropriate treatment at the optimal time.